collaboration with the vall d’hebron institute of oncology (vhio)
Published 4 weeks ago • 34 plays • Length 4:04Download video MP4
Download video MP3
Similar videos
-
2:54
vhio: translación hacia la oncología de precisión
-
1:23
growth factors
-
3:00
triple-negative breast cancer: what's the prognosis?
-
1:19
what if we could adapt cancer treatments as tumors mutate and change?
-
2:37
gene expression and cancer
-
6:49
how to place a 4.3 diameter v3 implant in a pre-molar site
-
11:06
how could new treatment options improve outcomes in flt3-mutated aml?
-
6:38
relapsed/refractory flt3-mutated aml
-
2:12
vaccine being tested to prevent what's called triple-negative breast cancer
-
0:23
you've been heard. #5
-
1:18
vhio's computational immunogenomics
-
2:55
adoptive cell therapies for solid cancers
-
2:37
v3 implant system – features and benefits, part i
-
0:23
you've been heard. #11
-
2:39
complement c3 inhibitor amy-101 in adults with periodontal inflammation – clinical trial
-
1:14
the importance of a biomarker-directed approach in triple-negative breast cancer
-
2:08
crenolanib plus 7 3 chemotherapy in adults with newly diagnosed flt3-mutated aml.
-
1:28
quizartinib provides clinical benefit in r/r flt3-itd aml
-
45:48
triple negative breast cancer
-
2:42
biomarker-driven therapies for triple-negative breast cancer
-
2:48
immunomodulatory effects of parp inhibition in brca1-deficient triple-negative breast cancer